title: Problems in assessing the possible disease-modifying effect of naproxen.
authors.forename: R A
authors.initials: RA
authors.lastname: Mitchell
authors.forename: D
authors.initials: D
authors.lastname: Woolf
authors.forename: C
authors.initials: C
authors.lastname: Murray-Leslie
authors.forename: E C
authors.initials: EC
authors.lastname: Huskisson
authors.forename: J
authors.initials: J
authors.lastname: Wojtulewski
authors.forename: B
authors.initials: B
authors.lastname: Ansell
authors.forename: S P
authors.initials: SP
authors.lastname: Liyanage
authors.forename: D
authors.initials: D
authors.lastname: Doyle
authors.forename: J
authors.initials: J
authors.lastname: Colston
authors.forename: J R
authors.initials: JR
authors.lastname: English
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001241:Aspirin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D011859:Radiography; D011897:Random Allocation
chemical_list: D009288:Naproxen; C010843:aloxiprin; D001241:Aspirin